XML 475 R47.htm IDEA: XBRL DOCUMENT v3.25.1
Directors' and prescribed officers' remuneration
12 Months Ended
Dec. 31, 2024
Disclosure of transactions between related parties [abstract]  
Directors' and prescribed officers' remuneration 39.  Related-party transactions
Sibanye-Stillwater entered into related-party transactions with Rand Refinery, and its subsidiaries during the year. The transactions with these
related parties are generally conducted with terms comparable to transactions with third parties, however in certain circumstances such as
related-party loans, the transactions were not at arm’s length.
See note 1.3 for the Group structure, which provides further detail on the relationship between the parent and subsidiary companies.
Blue Ridge
During 2024, an impairment allowance related to a receivable balance from Blue Ridge was recognised amounting to R118 million (see
note 24).
Reldan Mexico S. de R.L. de C.V. (Reldan Mexico)
During the year, the Group acquired a 72% investment in Reldan Mexico, through its wholly-owned subsidiary, Reldan International Holding
Company LLC (see note 16.1). For the year ended 31 December 2024, the Group purchased post-consumer e-scrap from Reldan Mexico
amounting to R372 million.
Rand Refinery
Rand Refinery, in which Sibanye-Stillwater holds a 44.4% interest, has an agreement with the Group whereby it refines all of the Group’s gold
production. For the year ended 31 December 2024, the Group received a dividend of R221 million (2023: R233 million and 2022:
R307 million) from Rand Refinery, and sold gold and paid refining fees to Rand Refinery. See note 18.1 for additional information in respect
of the Group’s investment in Rand Refinery.
The table below details the transactions and balances between the Group and its related parties:
Figures in million - SA rand
2024
2023
2022
Rand Refinery
Gold sales
818
710
187
Refining fees paid
(40)
(44)
(24)
Trade payable
(9)
(6)
(6)
Key management remuneration
Total key management personnel compensation recognised under IFRS Accounting Standards:
Figures in thousands - SA rand
2024
2023
2022
Short-term employee benefits1
194,057
138,209
127,542
Post-employment benefits
10,072
9,397
6,957
Share-based payment
44,047
34,578
65,338
Total
248,176
182,184
199,837
1Includes termination benefits of R29,590,540 (2023: R3,663,146)
40.  Directors' and prescribed officers' remuneration
The disclosure below incorporates remuneration for services rendered to various companies within the Group during the year.
The executive directors and prescribed officers were paid the following remuneration during the year:
Figures in thousands - SA rand
Salary
Cash bonus
accrued for
2024 paid in
2025
Accrual of
share-based
payment
benefits
Pension
scheme total
contributions
Expense
allowance
and other
benefits
2024
2023
2022
Executive directors
Neal Froneman1
16,197
15,121
16,403
1,520
1,615
50,856
56,334
198,032
Charl Keyter
7,646
6,968
7,835
1,092
23,541
25,701
87,482
Prescribed officers
Dawie Mostert2
14,513
50,765
Themba Nkosi
5,333
4,492
4,194
551
14,570
14,369
46,480
Richard Stewart
7,166
6,102
6,500
796
20,564
19,947
60,125
Robert van Niekerk
8,496
6,781
7,026
696
203
23,202
21,856
78,632
Laurent Charbonnier3
12,275
1,862
94
29,590
43,821
23,548
24,102
Lerato Legong
5,046
4,312
3,970
688
14,016
10,760
9,553
Mika Seitovirta4
9,338
7,726
5,151
3,145
1,294
26,654
23,971
15,899
Charles Carter5
13,812
11,242
7,495
1,105
326
33,980
24,322
17,008
Melanie Naidoo-Vermaak6
5,774
4,702
3,135
385
2,500
16,496
Total
91,083
67,446
63,571
10,072
35,528
267,700
235,321
588,078
1Entered into a dual service contract with effect 1 May 2018. Remuneration paid by Stillwater in US dollars was converted at the average exchange rate of R18.32/US$
(2023: R18.42/US$ and 2022: R16.37/US$) for the year ended 31 December 2024
2Ceased performing a prescribed officer role on 4 August 2023
3Remuneration paid in GBP was converted at the average exchange rate of R23.40/GBP (2023: R22.93/GBP and 2022: R20.18/GBP) for the year ended 31 December 2024.
Laurent ceased performing a prescribed officer role on 31 January 2025, expense allowance and other benefits includes a separation benefit of R29,590,540
4Remuneration paid in Euros was converted at the average exchange rate of R19.82/Euro (2023: R19.94/Euro, 2022: R17.20/Euro) for the year ended 31 December 2024
5Remuneration paid in US dollars converted at the average exchange rate of R18.32/US$ (2023: R18.42/US$, 2022:R16.37/US$)   
6Appointed 1 January 2024
The non-executive directors were paid the following fees during the year:
Figures in thousands - SA rand
Directors
fees
Committee
fees
Expense
allowance
2024
2023
2022
Timothy Cumming
1,212
1,275
107
2,594
2,535
2,212
Savannah Danson1
303
185
488
2,229
1,901
Harry Kenyon-Slaney
3,546
834
1,052
5,432
3,371
2,542
Richard Menell
2,124
528
58
2,710
3,610
2,735
Nkosemntu Nika2
404
247
9
660
1,927
1,843
Keith Rayner
1,212
2,124
3,336
2,655
2,296
Susan van der Merwe2
505
309
21
835
2,037
1,830
Jeremiah Vilakazi
1,212
989
2,201
1,994
1,662
Vincent Maphai
3,662
210
3,872
3,714
3,405
Elaine Dorward-King
1,747
1,385
1,069
4,201
2,799
2,803
Sindiswa Zilwa
1,212
1,142
2,354
2,146
1,821
Philipe Boisseau3
1,283
839
368
2,490
Peter Hancock4
1,166
1,172
1,113
3,451
Terence Nombembe5
448
227
675
Total
20,036
11,466
3,797
35,299
29,017
25,050
1Resigned as non-executive director on 11 March 2024
2Resigned as non-executive director on 28 May 2024
3Appointed on 8 April 2024
4Appointed on 6 May 2024
5Appointed on 11 September 2024
The directors’ and prescribed officers’ (including their associates) direct and indirect share ownership at 31 December 2024 was:
Number of shares*
%
2024
2023
2022
2024
2023
2022
Executive directors1
Neal Froneman2
1,829,452
3,284,428
8,559,665
0.06
0.12
0.30
Charl Keyter
1,776,481
1,776,481
1,466,181
0.06
0.06
0.05
Non-executive directors1
Timothy Cumming
20,000
20,000
6,000
Richard Menell
10,125
10,125
10,125
Keith Rayner
78,992
73,992
68,992
Susan van der Merwe3
1,028
1,028
Jeremiah Vilakazi
2,000
4,220
4,220
Vincent Maphai
228,224
228,224
199,724
0.01
0.01
0.01
Savannah Danson4
16,519
16,519
Harry Kenyon-Slaney5
16,852
16,852
16,852
Elaine Dorward-King
10,000
Total share ownership by directors
3,962,126
5,431,869
10,359,306
0.14
0.19
0.37
Prescribed officers1
Dawie Mostert6
136,302
136,302
Themba Nkosi7
251,583
251,583
251,583
0.01
0.01
0.01
Richard Stewart
788,771
788,771
788,771
0.03
0.03
0.03
Robert van Niekerk
490,429
490,429
1,766,770
0.02
0.02
0.06
Laurent Charbonnier8
151,012
151,012
151,012
0.01
0.01
0.01
Charles Carter9
680,000
580,000
300,000
0.02
0.02
0.01
Melanie Naidoo-Vermaak10
146,858
0.01
Total
6,470,779
7,829,966
13,753,744
0.23
0.28
0.49
*This is the shareholding at the reporting date unless otherwise stated
1Share ownership (including shares held by associates) in the Company at the date of this report was unchanged
2Neal Froneman and his associates hold 388,863 ADSs at 31 December 2024 (2023: 388,863, 2022: 225,408) which convert to 1,555,452 (2023: 1,555,452, 2022: 901,632)
ordinary shares in the Company
3Ceased performing a non-executive director role on 28 May 2024
4Last known shareholding when ceased performing a non-executive director role on 11 March 2024
5Harry Kenyon-Slaney and his associates hold 4,213 ADSs at 31 December 2024 (2023 and 2022:4,213) which convert to 16,852 (2023 and 2022: 16,852) ordinary shares in the
Company
6Last known shareholding when ceased performing prescribed officer role on 4 August 2023
7Themba Nkosi and his associates hold 5,300 ADSs at 31 December 2024 (2023 and 2022: 5,300) which convert into 21,200 (2023 and 2022: 21,200) ordinary shares in the
Company
8Laurent Charbonnier and his associates hold 37,753 ADSs at 31 December 2024 (2023 and 2022: 37,753) which convert to 151,012 (2023 and 2022: 151,012) ordinary shares
in the Company. The ordinary shares held by Laurent and his associates represents the last known shareholding when he ceased performing a prescribed officer role on
31 January 2025
9Charles Carter and his associates hold 170,000 ADSs at 31 December 2024 (2023: 145,000, 2022: 75,000) which convert to 680,000 (2023: 580,000, 2022: 300,000) ordinary
shares in the Company
10Melanie Naidoo-Vermaak was appointed on 1 January 2024